Question 1

What specific information will be collected about my child's health during this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin clinical trial (NCT05775523). Contact the study team or your healthcare provider for specific answers.

Question 2

How often will we need to come in for follow-up visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin clinical trial (NCT05775523). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks or side effects we should be aware of while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin clinical trial (NCT05775523). Contact the study team or your healthcare provider for specific answers.

Question 4

How does this study help improve the understanding of lonapegsomatropin's safety?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin clinical trial (NCT05775523). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my child stops responding to lonapegsomatropin during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin clinical trial (NCT05775523). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my child's participation affect their current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin clinical trial (NCT05775523). Contact the study team or your healthcare provider for specific answers.

What this study is about